Literature DB >> 7850982

A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.

D R Booth1, S Y Tan, P N Hawkins, M B Pepys, A Frustaci.   

Abstract

BACKGROUND: Amyloidosis is a disorder of protein metabolism characterized by extracellular accumulation of abnormal protein fibrils. Different proteins form the fibrils in different forms of the disease, and the condition can be acquired or hereditary. Involvement of the heart is quite common, producing a serious and usually fatal cardiomyopathy. Cardiac amyloidosis is often diagnosed late, and cardiac biopsy together with proper histological examination is essential. Contrary to previous perceptions, there is much recent evidence of effective treatment for several different types of systemic and cardiac amyloidosis, including the most common hereditary form caused by mutations in the transthyretin gene. Chemical and genetic typing of amyloid is therefore of considerable clinical importance. METHODS AND
RESULTS: Seven members in two generations of an Italian family presented with cardiac disease inherited as an autosomal dominant and were found to have systemic amyloidosis. Angina pectoris-like pain, an unusual feature in cardiac amyloidosis, was a prominent symptom, possibly related to partial obliteration of the distal coronary arteries by amyloid infiltration. There were also cases of sudden cardiac death. Peripheral and autonomic neuropathy, which are the usual features of hereditary amyloidosis, were present in only two cases, and a diagnosis of acquired, immunoglobulin light chain (AL type) amyloidosis was suspected in the index case before the family history emerged. In fact, the amyloid fibrils were composed of transthyretin, and the two affected individuals from whom DNA was available were both heterozygotes for a single base change in exon 3 of the transthyretin gene, encoding substitution of Lys for the wild-type Thr residue at position 59 in the mature protein. This mutation has not previously been reported.
CONCLUSIONS: We have identified a novel mutation in the transthyretin gene encoding 59Thr-->Lys associated with autosomal dominant hereditary systemic amyloidosis in an Italian kindred in whom cardiac involvement was the major feature. This family illustrates the difficulty in diagnosis of cardiac amyloid, the variable clinical phenotype in hereditary amyloidosis even within a family, and the importance of precise fibril typing for correct management in this condition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7850982     DOI: 10.1161/01.cir.91.4.962

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  PCR analysis in archival postmortem tissues.

Authors:  S Bonin; F Petrera; B Niccolini; G Stanta
Journal:  Mol Pathol       Date:  2003-06

2.  Hereditary hepatic and systemic amyloidosis caused by a new deletion/insertion mutation in the apolipoprotein AI gene.

Authors:  D R Booth; S Y Tan; S E Booth; G A Tennent; W L Hutchinson; J J Hsuan; N F Totty; O Truong; A K Soutar; P N Hawkins; M Bruguera; J Caballería; M Solé; J M Campistol; M B Pepys
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

3.  Cardiac Amyloidosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-10

4.  An elderly male with tingly legs and a heavy heart: Persisting with the diagnosis!

Authors:  Mudassar Kharadi; Sreenath Vedula Harsha; Gayathri Gopalakrishnan; G A Karthick; Vimal Raj; Subramanian Kannan
Journal:  Ann Indian Acad Neurol       Date:  2016 Oct-Dec       Impact factor: 1.383

Review 5.  Is Vascular Amyloidosis Intertwined with Arterial Aging, Hypertension and Atherosclerosis?

Authors:  Yushi Wang; Xiaoxing Feng; Botao Shen; Jing Ma; Waiou Zhao
Journal:  Front Genet       Date:  2017-10-06       Impact factor: 4.599

6.  Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population.

Authors:  Andreea Jercan; Amalia Ene; Ruxandra Jurcut; Mirela Draghici; Sorina Badelita; Mihaela Dragomir; Camelia Dobrea; Monica Popescu; Dumitru Jardan; Emanuel Stoica; Speranta Iacob; Ionela Codita; Claudiu Stan; Daniel Coriu
Journal:  Orphanet J Rare Dis       Date:  2020-01-30       Impact factor: 4.123

7.  Senile systemic amyloidosis: clinical features at presentation and outcome.

Authors:  Jennifer H Pinney; Carol J Whelan; Aviva Petrie; Jason Dungu; Sanjay M Banypersad; Prayman Sattianayagam; Ashutosh Wechalekar; Simon D J Gibbs; Christopher P Venner; Nancy Wassef; Carolyn A McCarthy; Janet A Gilbertson; Dorota Rowczenio; Philip N Hawkins; Julian D Gillmore; Helen J Lachmann
Journal:  J Am Heart Assoc       Date:  2013-04-22       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.